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ABSTRACT 
Cytochrome P450 (P450) enzymes participate in a wide array of metabolic reactions. Of these P450s, CYP2B subfamily plays an 
important role in the metabolism of endogenous compounds and xenobiotics. CYP2B1 and CYP2B2 in rats and CYP2B9 and CYP2B10 
in mice are major CYP2B isoenzymes constitutively and inducible expressed. Their constitutive expression is sexually dimorphic, 
specifically more expression in male than female rats, and more in female than male mice. Recent studies have shown that regulation of 
CYP2B expression is markedly influenced by not only various endogenous and exogenous compounds, but also age, sex, strain, and 
nutritional status. Regarding regulation of P450 expression in mouse liver, a C57BL/6 strain is one of the most suitable mouse models 
because of its marked response to CYP2B induction. The regulation of sexual dimorphism of CYP2B highly depends on numerous 
endogenous hormones including glucocorticoids, sex hormones and growth hormones. Adrenalectomy suggested that glucocorticoids 
induced CYP2B10 but simultaneously suppressed CYP2B9 expression in both sexes. β-estradiol (ES) up-regulated the expression of 
CYP2B9, while testosterone showed reverse activity of ES. Hypophysectomy and the age-expression profile revealed that growth 
hormone (GH) exerts suppressive effect on regulation of CYP2B9 and CYP2B10 expression in the males, but only on CYP2B10 in the 
females. Xenobiotics, i.e., phenobarbital, dexamethasone, DDT (1, 1, 1-trichloro-2, 2-bis (p-chlorophenyl) ethane), are exogenous factors 
influencing the CYP2B expression. For example, phenobarbital and DDT induce both CYP2B9 and CYP2B10 while dexamethasone 
predominantly induces CYP2B10, but simultaneously suppresses CYP2B9. Therefore, the factors that affect regulation of CYP2B 
expression should be thoroughly considered to eliminate their confounding effects, leading to accurate and precise outcome measures.  
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Introduction  
§It is unavoidable for all organisms to expose foreign 
chemicals, or xenobiotics. These xenobiotics, both 
manufactured and natural in nature, include drugs, industrial 
chemicals, pesticides, pollutants, secondary plant 
metabolites, and toxins produced by molds, plants, and 
animals. The physical property that enables many 
xenobiotics to be absorbed through the skin, lung, or 
gastrointestinal track, namely lypophillicity, is an obstacle to 
their elimination, because lipophillic compound is readily 
reabsorbed.1 Consequently, elimination of xenobiotic often 
depends on their conversion to water-soluble chemicals by 
process known as biotransformation or metabolism. Drug is 
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one of important xenobiotics. In general, drug metabolizing 
reactions are divided into phase I and phase II reactions. 
Phase I reaction involves chemical alteration of drug 
structure by oxidation, reduction, or hydrolysis. In phase II 
reaction, the drug molecule is conjugated by glucuronidation, 
sulphation, or acetylation.2 Cytochrome P50 superfamily 
(P450) is an important enzyme system in phase I of drug 
metabolism. P450s require a cytochrome P450 reductase to 
transfer electron from NADPH to their substrate (Figure 1). 
This process converts dugs or chemical compounds to 
water-soluble compounds to be excreted in urine or feces.3 
P450s, which are heme-containing protein, are found in the 
endoplasmic reticulum and mitochondria. In human, they are 
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synthesized predominantly in the liver and, to a lesser 
extent, in the small intestine, kidney, adrenal, and other 
sites. While the P450 enzymes have extremely broad 
substrate and product specificities, an individual enzyme 
often exhibits a high specificity toward a certain substrate.4 
CYP2B is a large subfamily that encodes versatile catalysts 
of xenobiotics and steroid hydroxylation. Even closely related 
isoforms display distinct sex- and tissue-specific regulation.5 
A hallmark for CYP2B gene regulation is the strong 
inducibility of some isoforms by structurally diverse 
xenobiotics, including industrial solvent, barbiturates, 
antimycotics, and pesticides.6 These chemicals are typified 
by phenobarbital (PB) and they can up-regulate several 
hepatic enzymes involved in xenobiotic metabolism and 
other genes as well.7   
 
 
Figure 1 The cytochrome P450 system. 
 
Rolf of CYP2B in Xenobiotic Metabolism  
CYP2B6 which belongs to CYP2B subfamily has been 
studied extensively in many species. CYP2B6 appears to be 
the functional gene expression in human.8 This enzyme 
catalyzes many reactions such as the O-dealkylation of 7-
ethoxy-4-trifluoromethylcoumarin, the N-demethylation of 
benzphetamine, and the O-dealkylation of benzylo-
xyresorufin. However these reactions are not selective for 
CYP2B6. CYP2B6 plays a role in the metabolism of 
endogenous substrates including testosterone steroid.9 
Phenobarbital (PB) primarily induces the corresponding 
CYP2B enzymes in other species. For example CYP2B9/10, 
CYP2B1/2, CYP2B11, and CYP2B17 are the major 
phenobarbital-inducible P450 isoforms in mouse, rat, dog, 
and cynomolgus monkey, respectively. CYP2B genes are 
regulated physiologically by thyroids hormones, gluco-
corticoids, and growth hormone8, which all remain under the 
control of the central nervous system.10 At molecular level, 
the nuclear receptors-constitutive androstrane receptor 
(CAR), pregnane X receptor (PXR), and glucocorticoid 
receptor (GR) participate in their regulation.11  
 
Regulation of CYP2B Expression  
Besides nuclear receptors, level of drug metabolizing 
enzymes are influenced by a numerous factors, such as age, 
genetic background, physiologic state, disease, nutritional 
status as well as exposure to drugs, hormones, and 
environmental chemicals. Hence, factors that affect sexual 
dimorphic expression of CYP2B including sex, age, strain as 
well as some endogenous hormones and xenobiotics are 
discussed as follows.   
 
The Difference of Strains 
A vertebrate model commonly used as animal model is 
mouse because of their availability, size, low cost, ease of 
handling, and high reproduction rate.12 Because of these 
reasons, mouse models were used for genetic analysis of 
CYP2B9 expression. PB has served as a prototype for a 
large group of structurally and functionally diverse xeno-
chemicals that induce CYP2B gene. 
Damon et al investigated the effect of genetic background 
on PB-inducibility of CYP2B9 and CYP2B10 mRNA 
expression by semi-quantitative specific RT-PCR in five 
inbred mouse strains including A/J, BALB/cByJ, C57BL/6J, 
DBA/2J, and SWR/J.13 Male mice constitutively expressed 
CYP2B9 and CYP2B10 mRNAs, but a number of differences 
in their response to PB were observed. In all these mouse 
strains, PB induced CYP2B10 mRNA whereas it had either a 
positive or a negative effect on CYP2B9 expression, 
depending on strain and sex of the mice.  
The results from Figure 2 suggested that the genetic basis 
for PB-induction in mice depended on the target gene, and 
that more than one regulatory step would be involved in this 
response pathway. 
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Figure 2 Regulation of CYP2B9 and CY2B10 mRNAs by 
Phenobarbital (PB) in male and female mice.13 (A) 
RT-PCR analyses on 250 ng (CY2B9) and 100 ng 
(CYP2B10) of total RNA for both control and PB-treated 
animals. PCR products were analyzed by Southern blotting 
and hybridized with a full-length rat CYP2B1 cDNA probe. 
(B) CY2B9 PCR products were obtained from 50 ng 
(untreated and PB-treated D2 mice), or 100 ng (untreated 
and PB-treated B6 mice) of total RNA. CYP2B10 PCR 
products were obtained from 100 ng of total RNA.  PCR 
products were also analyzed by Southern blotting and 
hybridized with a full-length rat CYP2B1 cDNA probe.  
 
 
The regulatory mechanism behind the expression of 
CYP2B9 mRNA, a female-specific species inducibly 
expressed in the mouse liver, has yet to be elucidated. A 
potent inducer is needed to investigate the regulatory 
pathway of CYP2B9 expression. The next study of 
Jarukamjorn et al investigated the inducible expression of 
CYP2B subfamily in male C57BL/6 (B6) and DBA/2 (D2) 
mice, as well as their hybrids (B6D2F1) at the mRNA level 
by using semi-quantitative RT-PCR.14 The result 
demonstrated that the expression of hepatic CYP2B mRNAs 
in the B6 was lightly induced by β-estradiol (ES), while that 
by PB or 1,1,1-trichloro2,2-bis (p-chlorophenyl) ethane (DDT) 
was prominent. Discriminating analysis showed a novelty 
that ES markedly induced CYP2B9 mRNA expression, 
whereas PB and DDT increased CYP2B10 more than 
CYP2B9 expression: albeit both mRNA species responded 
to all three inducers (Figure 3). Especially, the specific 
induction by ES of CYP2B9 mRNA in B6 male mice, but not 
D2 male mice, suggested strain dependency in the 
regulatory pathway of CYP2B9 expression.  
 
 
Figure 3 Induction of hepatic CYP2B9 and CYP2B10 mRNA 
expression by P450 inducers in C57BL/6 mice.14 
Adult C57BL/6 mice were daily subcutaneously treated with 
DDT at 100 mg/kg/day for 3 days, or ES at 0.5 mg/kg/day 
for 7 days, as well as PB intraperitoneally at 100 mg/kg/day 
for 3 days. The animals were killed 24 h after the last 
injection to prepare total RNA. Discrimination analysis of 
expressed CYP2B9 and CYP2B10 mRNA by RT-PCR. Note: 
NT, no treatment; DDT, 1,1,1-trichloro-2,2-bis(p-chloro 
phenyl) ethane; ES, β-estradiol benzoate; PB, phenobarbital 
sodium; H, HhaI; B, BglII; PCR 28 cycles; 1 and 2 indicate 
individual animals.  
 
The Influence of Endogenous Hormones 
Of the endogenous factors studied, hormones appear to 
have considerable influence on the expression or activity of 
CYP2B enzymes. CYP2B genes are regulated 
physiologically by thyroid hormones, glucocorticoids, and 
growth hormone. Thus endogenous hormones are 
candidates in activating or depressing CYP2B gene 
expression.15   
The first example study by Nemoto and Sakurai 
investigated the effects of growth hormone (GH) and 
glucocorticoid on the expression of CYP2B9/10 mRNA in 
C57BL/6NCrj mice-hepatocytes by RT-PCR.15 They found 
that treatment with PB increased the expression of CYP2B10 
more than CYP2B9 in both sexes. β-estradiol also induced 
both gene expressions in male liver, but more effect on 
CYP2B10 than CYP2B9 was observed. In the female liver, 
β-estradiol and testosterone slightly increased the levels of 
CYP2B10, whereas the expression of CYP2B9 was reduced 
(Figure 4). Dexamethasone induced more expression of 
more CYP2B10 mRNA than that of CYP2B9. Ovarectomy 
did not reduce the expression of these two mRNAs, but 
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rather increased them and the PB-inducible and non-
inducible expressions of CYP2B9/10 mRNA were very 
slightly inhibited by GH regardless of sex.  
 
 
Figure 4 Expression of CYP2B9/10 mRNA in mouse liver.15 
Male and female C57BL/6 mice were injected with 400 μg 
testosterone propionate or 10 μg β-estradiol or 100 mg/kg 
phenobarbital. The animals were killed 24 h after the last 
injection. (A) Total liver RNA was Northern-blotted using a 
cDNA probe for CYP2B10. (B) One microgram of total RNA 
was reverse-transcribed and then amplified. Note: C, control 
; E, β-estradiol; T, testosterone; PB, phenobarbital; B, BglII; 
H, HhaI;1, CYP2B9; 2, CYP2B10. 
 
Jarukamjorn et al demonstrated the constitutive and 
inducible expression of CYP2B9/10 in mouse liver and 
culture hepatocytes.6 The results showed that PB induced 
both CYP2B9 and CYP2B10 while dexsamethasone 
predominantly induced CYP2B10, but simultaneously 
suppressed CYP2B9 (Figure 5). Adrenalectomy increased 
the expression of CYP2B9 and CYP2B10 mRNAs, especially 
that of CYP2B9 in the male liver. In addition, the expression 
of one unknown species, which was constitutively 
suppressed, was increased in adrenalectomized male mice 
(Figure 6). The treatment of dexamethasone or 
adrenalectomy altered the expression of CYP2B subfamilies 
suggesting that endogenous glucocorticoid hormone plays a 
basic role in the constitutive expression of cytochrome P450. 
 
 
 
Figure 5 Expression of CYP2B9 and CYP2B10 in the mouse 
liver.6 Male and female C57BL/6 mice were injected three 
times with 10 mg dexamethasone or 100 mg phenobarbital/ 
kg/day. The animals were killed 24 h after the last injection. 
(A) Total RNAs were Northern-blotted using a cDNA probe 
for Cyp2b10. (B) Western blotting of the hepatic microsomal 
proteins. Note: C, control; Dex, dexamethasone; PB, pheno- 
barbital. 
 
 
Figure 6 Expression of CYP2B9 and CYP2B10 mRNAs after 
adrenalectomy.6 Four-week-old C57BL/6 mice were 
adrenalectomized and killed 5 days later. Total RNA was 
prepared from the liver and amplified by RT-PCR. Note: Ad 
(-), adrenalectomized mice. PCR cycles: male, 28; female, 
20; n, none; B, BglII; H, HhaI.  
 
Furthermore, the sex-related difference in the expression 
of CYP2B9 and CYP2B10 suggested that sex-dependent 
secretion of endogenous modulating factors was involved in 
the regulatory pathway.  
Jarukamjorn et al examined sexual dimorphism in mouse 
CYP2B by investigating the developmental modification of 
the expression during maturation stage and by determining 
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the role of growth and sex hormones on the regulatory 
mechanism of this enzymes, using northern hybridization 
and RT-PCR.16 The results revealed that during the 
prepubertal stage, the constitutive expression of hepatic 
CYP2B mRNA was similar in both sexes (Figure 7A). The 
expression was increased in pubertal female mice, whereas 
those in males gradually declined to nearly undetectable 
levels after puberty and CYP2B9 mRNA was the principal 
isoform expressed during prepuberty in both sexes (Figure 
7B). During the maturation stage, CYP2B10 was expressed 
in both sexes, while CYP2B9 was diminished markedly in 
the male, resulting in a sexually dimorphic expression in 
adult mice. Hypophysectomy eliminated the sexual 
dimorphism in the mouse CYP2B subfamily by markedly 
increasing the expression of both CYP2B9 and CYP2B10 in 
males to levels similar to those in females (Figure 8). On the 
other hand, expression of CYP2B9 in females was almost 
unchanged, even after hypophysectomy. Thus the ratio of 
CYP2B9/CYP2B10 mRNA was increased significantly in 
male but not female mice.  
Treatment of hypophysectomized mice of both sexes with 
sex hormones reduced the ratio of CYP2B9/CYP2B10 
according to the increase of CYP2B10, except in the case of 
testosterone-treated hypophysectomized male mice (Table 
1). This result indicates the possibility that estrogen can 
regulate CYP2B10 gene expression. The results suggest 
that beside glucocorticoid hormones, the pituitary factor may 
be one of the expressions of the CYP2B subfamily in mouse 
liver.
 
 
 
Figure 7 Developmental profile of CYP2B mRNA expression during maturation.17 ddY mice of both sexes were 
killed at the indicated ages. (A) 10 micrograms of total hepatic RNA was northern-blotted and hybridized using a cDNA 
probe for CYP2B10 gene. The blots were normalized to the signal for GAPDH mRNA. The relative mRNA level was 
determined densitometrically from autoradiographs and presented with age as a line graph (N = 3: mean ± SD). (B) 
Discrimination of the developmental expression of CYP2B9 and CYP2B10 mRNA by RT-PCR. Restriction enzymes: B, 
BglII; H, HhaI. A representative experiment of three is shown.  
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Figure 8 Modification of CYP2B mRNA expression by hypophysectomy and sex hormone supplementation.16 
17β-Estradiol benzoate (ES) or testosterone propionate (TE) was administrated subcutaneously to hypophysectomoized 
or sham-operated C57BL/6 mice of both sexes. The mice were killed 24 h after the last injection. Note: NT, no 
treatment; Restriction enzymes: B, BglII; H, HhaI. A representative experiment of three is shown. 
 
Table 1 Modification of CYP2B mRNA expression by hypophysectomy and sex hormone supplementation16).  
Relative expression 
Male  Female Operation Treatment 
CYP2B9 CYP2B10 Ratio  CYP2B9 CYP2B10 Ratio 
Sham-operation No treatment 1.05 ± 1.28 0.96 ± 0.66 1.09  11.89 ± 0.58 1.00 ± 0.05 11.89 
Hypophysectomy No treatment 8.03 ± 0.48* 1.65 ± 0.11 4.87  10.94 ± 2.08 1.61 ± 0.51 6.79 
 Estradiol 7.64 ± 0.57 2.31 ± 0.75 3.31  10.54 ± 1.22 3.67 ± 0.75** 2.87 
 Testosterone 7.83 ± 0.51 1.53 ± 0.48 5.12  11.03 3.50*** 3.15 
Results are expressed as mean ± SD or as the mean of radioactivity from 3 or 2 individual mice per group, respectively.  
* Significantly different from the non-treated sham-operated group (P < 0.01).  
** Significantly different from the non-treated hypophysectomized group (P < 0.01).  
*** Significantly different from the non-treated hypophysectomized group (P < 0.05).  
 
Conclusions and Perspectives  
The P450 genes encode a superfamily of heme-thiolate 
proteins responsible for the oxidative metabolism of 
chemically diverse compounds of both endogenous and 
exogenous origin. The toxicity of certain xenobiotics, such as 
mutagents and carcinogens, is enhanced by P450-
dependent metabolism in some cases.17 CYP2B subfamily 
accounts for one of the P450s expressed in the liver which 
participates in the metabolism of endogenous hormones and 
xenobiotics18 and one of the prototypic examples of sex-
dependent differences in hepatic profiles.16 There are many 
factors that can affect the regulation of the CYP2B 
expression such as age, gender, genetic background, 
physiologic state, disease, and nutritional status as well as 
exposure to drugs, hormones, and environmental chemicals1. 
A mouse model commonly used as animal model because of 
their availability, size, low cost, ease of handing, and high 
reproduction rate.12 The study on expression of CYP2B 
among 5 mouse strains including A/J, BALB/c, C57BL/6J, 
DBA/2J, and SWR/J by phenobarbital showed that CYP2B10 
was inducible in all 5 mouse strains while CYP2B9 was 
inducible in most mouse strains except DBA/2.13 
Consideration on regulation of CYP2B expression in mouse 
liver, a C57BL/6 strain is one of the most suitable mouse 
models because of its high response to CYP2B inducers. 
The regulation of sexual dimorphism of CYP2B highly 
depends on numerous endogenous hormones including 
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glucocorticoids, sex hormones and growth hormones. 
Glucocorticoid hormones which are produced by adrenal 
gland, suppressed the CYP2B9 expression in both sexes. 
Simultaneous induction of CYP2B10 with suppression of 
CYP2B9 mRNAs by the treatment of dexamethasone, a 
synthetic glucocorticoid hormone, as well as an increase of 
CYP2B9 expression level in adrenalectomized mice 
supported that glucocorticoid hormones function as a key 
suppressor on CYP2B9 mRNA. A female sex hormone 
(estradiol) increased the level of CYP2B9 expression, 
whereas the level of this enzyme was reduced by a male 
sex hormone (testosterone). Hypophysectomy eliminated the 
sexual dimorphism in CYP2B subfamily by increasing the 
expression of both CYP2B in the males to nearly the same 
level as that in the females. These observations suggested 
that growth hormone participated in down-regulation of 
CYP2B9 expression in the males at least in part. Drugs or 
xenobiotics, i.e., phenobarbital, dexamethasone, DDT (1,1,1-
trichloro-2,2-bis(p-chlorophenyl) ethane), are exogenous 
factors influencing the CYP2B expression. For example, 
phenobarbital and DDT induced both CYP2B9 and CYP2B10 
while dexamethasone predominantly induced CYP2B10, but 
simultaneously suppressed CYP2B9. In conclusion, the 
factors affecting regulation of CYP2B expression should be 
thoroughly considered to eliminate confounding factors, 
leading to accurate and precise outcomes.  
The study in recent years found that CYP2B6 gene 
regulation in human influenced by the constitutive 
androstane receptor (CAR), which is a nuclear receptor that 
mediated the hepatic regulation and expression of a wide 
variety of genes involved in endobiotic and xenobiotic 
clearance.19 CAR demonstrated a greater sexual dimorphic 
activity in females than males. Estrogens activated CAR and 
this may increase CAR activity in females relative to 
males.20,21 Furthermore, androgens also inhibited CAR 
activity in mice22, and this may reduce CAR activity in males 
relative to females. Altogether, these findings indicated that 
CAR may have greater activity in female mice and therefore 
help control and maintain basal and inductive expression of 
several sexually dimorphic CYPs.23 Therefore, regulation 
mechanism of nuclear receptors mediated CYP2B 
expression is an interesting factor worth for further 
consideration.  
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